ATARA BIOTHERAPEUTICS, INC. Operating Lease Liability
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Operating Lease Liability of $9.88 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability $9.88M.
- 2026-03-31: Operating Lease, Liability $10.09M.
- 2025-12-31: Operating Lease, Liability $10.38M.
- 2025-09-30: Operating Lease, Liability $16.96M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $9.88M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $10.09M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $10.38M 10-K · filed 2026-03-16 |
| 2025-09-30 | $16.96M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $17.67M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $39.55M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $42.79M 10-K · filed 2025-03-07 |
| 2023-12-31 | $56.96M 10-K · filed 2024-03-28 |
| 2022-12-31 | $70.87M 10-K · filed 2023-02-08 |
| 2022-09-30 | $72.10M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $74.67M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $28.10M 10-K · filed 2022-02-28 |
| 2020-12-31 | $14.77M 10-K · filed 2021-03-01 |
| 2019-12-31 | $15.45M 10-K · filed 2020-02-27 |
| 2019-09-30 | $15.69M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $15.88M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $15.08M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $15.30M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |